SanBio Company Limited (SNBIF) Financials
SNBIF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| April 30, 2026 | 92.3 million | 11.7 million |
| Jan. 31, 2026 | 100.9 million | 13.0 million |
| Oct. 31, 2025 | 15.6 million | 12.4 million |
| July 31, 2025 | 21.5 million | 12.8 million |
SNBIF Free Cash Flow and Stock based compensation
No data available :(
SNBIF Net Income
No data available :(
SNBIF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| April 30, 2026 | 89.0 million | 7.1 million | - |
| Jan. 31, 2026 | 97.5 million | 7.2 million | - |
| Oct. 31, 2025 | 12.4 million | 7.2 million | - |
| July 31, 2025 | 18.3 million | 7.3 million | - |
SNBIF Shares Outstanding
SNBIF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| April 30, 2026 | - | 4.3 million | 1.7 million | - |
| Jan. 31, 2026 | - | 4.9 million | 2.3 million | - |
| Oct. 31, 2025 | - | 3.7 million | 1.4 million | - |
| July 31, 2025 | - | 4.2 million | 1.7 million | - |
SNBIF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| April 30, 2026 | - | 25536 |
| Jan. 31, 2026 | - | 14757 |
| Oct. 31, 2025 | - | 12588 |
| July 31, 2025 | - | 85 |
SNBIF
Price: $16.45
52 week price:
Earnings Per Share: -0.33 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.3 billion